14th Oct 2014 08:57
LONDON (Alliance News) - Oxford Biomedica PLC Tuesday said Chief Development Officer Paul Blake bought 243,902 shares at a price of 4.1 pence per share Monday.
Following this transaction, Blake holds 2.3 million shares, which represents 0.09% of the total voting rights.
Shares in the biopharmaceutical company were up 2.3% at 3.99p Tuesday morning.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Biomedica